Lightnews — Scholar-powered news

Reposted by Erica Wood

Helen Bevan @helenbevan.bsky.social · Feb 10

Addressing power gradients (gap between those with the most & least power in a team or system) is THE most effective lever for increasing psychological safety within a team. Many ways to take action for this:
psychsafety.com/reducing-pow.... By jadegarratt.bsky.social via tomgeraghty.bsky.social

10 35

Reposted by Erica Wood

Blood Journals' Portfolio @bloodjournals.hematology.org · 12d

Somatic preleukemic GATA1s mutations are acquired before birth in 25% of neonates with DS, and are not acquired postnatally. buff.ly/vKCMYCm #hemesky

1 4

Reposted by Erica Wood

Women in Lymphoma @womeninlymphoma.bsky.social · 19d

WiLing Wednesday's Webinars are back! Join us for updates on various MCL topics presented by global experts, starting Oct 29 through to Nov 19.
Register on our website : womeninlymphoma.org/webinars
First session on Oct 29 : us06web.zoom.us/webinar/regi...

3 3

Erica Wood @ericawood.bsky.social · 6d

Looking forward to the next International Haemovigilance Network webinar on 21 October: "Partnering with patients is key to safer transfusion"
All are welcome, and it's free to register:
ihn-org.com/webinars/par...

2

Erica Wood @ericawood.bsky.social · 15d

Great to see the platelet findings from the prospective worldwide InPUT study of transfusion practice in intensive care. Just published in Crit Care Med.
doi: 10.1097/CCM.0000000000006880
@bloodsynergy.bsky.social

1 4

Erica Wood @ericawood.bsky.social · 15d

What is the implication of bulky disease on treatment and outcomes for patients with lymphoma? Read this analysis from the Australasian Lymphoma and Related Diseases Registry @lardr.bsky.social, led by Monash PhD student Eliza Chung.

haematologica.org/article/view...

Early View | Haematologica

haematologica.org

2

Reposted by Erica Wood

Lymphoma and Related Diseases Registry @lardr.bsky.social · Sep 9

⭐️⭐️⭐️ The 9500th participant ⭐️⭐️⭐️was recruited to the Lymphoma and Related Diseases Registry!
Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.

1 4

Erica Wood @ericawood.bsky.social · 15d

Happy to be representing the Australian Haemoglobinopathy Registry at ASCA's 4th Sickle Cell Scientific Conference.
24 October 2025, in person at Perth Children's Hospital, or online.
Everyone is welcome!
More info/registration: aussicklecelladvocacy.org

1 3

Reposted by Erica Wood

Blood Journals' Portfolio @bloodjournals.hematology.org · 19d

🌍 September is Sickle Cell Disease Awareness Month and together we are working to #ConquerSCD!
📚 Identifying pediatric patients with sickle cell disease at high risk of experiencing chronic pain after HSCT
📖 Read the full article here. buff.ly/AgBdW37

2 1

Erica Wood @ericawood.bsky.social · 26d

Nice work, Dr Sarah Zhao!
Aust/NZ Myeloma & Related Diseases Registry real-world comparison of outcomes for older transplant-ineligible pts. Better PFS outcomes for first-line VRd than Rd or VCd. Prospective studies are needed to establish optimal induction therapy.
doi: 10.1016/j.clml.2025.08.004

1

Erica Wood @ericawood.bsky.social · 26d

Thanks @who.int for emphasising the importance of preventing and treating non-communicable diseases to improve outcomes for people worldwide

WHO @who.int · 26d

⚠️Cardiovascular diseases.
⚠️Cancer.
⚠️Chronic respiratory diseases.
⚠️Diabetes.

They are silent and deadly.

Every year these diseases claim millions of lives.

Bold policies & healthier environments can stop these #SilentKillers in their tracks.

Change is within our reach 👉 bit.ly/UNGAHLM4 #UNGA

1

Erica Wood @ericawood.bsky.social · 26d

Hope you can join us, in person in Perth, or online, for the Myeloma and Related Diseases Registry annual breakfast meeting, this year on Mon 27 October as part of the Blood/ISBT conference.
All are welcome and there is no cost to attend.
More info/registration link:
www.mrdr.net.au/news/mrdr-an...

1 3

Reposted by Erica Wood

International Society on Thrombosis and Haemostasis @isth.org · Sep 3

📰 New in research: Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors.

This important study adds to the growing evidence base on optimizing anticoagulant strategies to reduce recurrence risk: bit.ly/4lZwh7g

Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors

Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, accor...

bit.ly

3 4

Erica Wood @ericawood.bsky.social · Sep 3

Looking forward to the Lymphoma & Related Diseases Registry @lardr.bsky.social annual breakfast meeting at BLOOD!
A partnership with Lymphoma Australia and Australasian Lymphoma Alliance.

In Perth + online on Tues 28 October.

Everyone is welcome!

Register: www.eventbrite.com.au/e/alalardrla...

Lymphoma and Related Diseases Registry @lardr.bsky.social · Aug 15

📣 Register now for the hybrid Lymphoma Breakfast Meeting!

Join us online to hear updates on our work, presented alongside the Australian Lymphoma Alliance and Lymphoma Australia.

🥐☕ Breakfast will be provided for on-site attendees.

ALA/LaRDR/LA Lymphoma Breakfast Meeting

Please join us for breakfast during BLOOD 2025

www.eventbrite.com.au

1 1

Erica Wood @ericawood.bsky.social · Sep 1

Delighted to report that a new Centre of Research Excellence in supportive care for people with blood cancers (BloodCare) has been funded by the NHMRC!
Congratulations to chief investigator, Prof Zoe McQuilten and all our team.
Look forward to sharing more as we get started on this important work!

2

Reposted by Erica Wood

American Society of Hematology @ash.hematology.org · Aug 27

Can sickle red blood cells harm blood vessels without blocking them? Tomorrow’s ASH Journal Club explores how rigidity and altered shear stress spark vascular inflammation. Register now: https://bit.ly/4lbfEFV

#HemeSky #MedSky

1 2

Reposted by Erica Wood

JAMA @jama.com · Aug 25

Most viewed this week from JAMA: Restrictive platelet transfusion strategies are recommended to minimize adverse reactions, mitigate platelet shortages, reduce costs, and ensure patient-centric care.

ja.ma/45yYrkQ

2 5

Reposted by Erica Wood

University of Oxford @ox.ac.uk · Aug 15

NEW: Oxford researchers have discovered an unexpected and powerful new function for platelets.

Platelets act as scavengers, capturing and storing fragments of DNA that are circulating in the blood, including fetal DNA and mutated DNA from cancer cells. ⬇️
www.ox.ac.uk/news/2025-08...

Platelets shown to store DNA in study that could transform cancer

Oxford-led study uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.

www.ox.ac.uk

1 15 30

Erica Wood @ericawood.bsky.social · Aug 8

Thanks to everyone who joined us, in person and online, for the OPTIMAL Centre of Research Excellence in improving immunoglobulin use workshop and open meeting.
Your participation is vital to the work of the CRE! You can find out more about us, and how to get involved, at: www.optimalcre.org

3

Reposted by Erica Wood

Women in Lymphoma @womeninlymphoma.bsky.social · Jul 24

Register for next week's webinar
"Infections and Lymphoma - Post-treatment Risk for Infection" with Dr Sairah Ahmed, Dr Mini Kamboj-Gill, Dr Swetha Thiruvengadam, Dr Soni Smith and Dr Florence Broussais-Guillaumot

us06web.zoom.us/webinar/regi...

1 3 4

Reposted by Erica Wood

The Lancet @thelancet.com · Jul 28

Globally, more than 300 million individuals are living with hepatitis B or C.

On #WorldHepatitisDay, explore a @lancetgastrohep.bsky.social Commission examining progress made towards hepatitis elimination & key themes that require further action to meet 2030 targets: tinyurl.com/2eexsumd

Lancet infographic outlining WHO targets and a three-point action plan for hepatitis elimination.

1 4

Erica Wood @ericawood.bsky.social · Jul 28

OPTIMAL @optimal-cre.bsky.social is an NHMRC Centre of Research Excellence in improving immunoglobulin use.
www.optimalcre.org

Our open meeting is coming up on Friday 1 August.
Everyone is welcome, in person (Melbourne 🇦🇺), or online.

More info + registration: 👉 OPTIMALCRE2025.eventbrite.com.au

Erica Wood @ericawood.bsky.social · Jul 21

Hope to see you in Perth for #BLOOD2025 and @isbt.bsky.social in October!

International Society of Blood Transfusion @isbt.bsky.social · Jul 21

Just 1 month left to grab your Early Bird registration for #BLOOD2025 & #ISBTPERTH 2025!

4 days of cutting-edge science, global collaboration, and innovation await. Don’t miss out on the best rates to join the leaders in transfusion medicine and blood banking.

www.blood-isbt-2025.com

Home - Blood-ISBT 2025 Meeting - Perth Convention and Exhibition Centre

On behalf of the Organising Committees, we look forward to welcoming you to Perth for Blood ISBT 2025. Blood is the combined Annual Scientific Meeting of the Haematology Society of Australia and New Z...

www.blood-isbt-2025.com

1

Reposted by Erica Wood

Women in Lymphoma @womeninlymphoma.bsky.social · Jul 17

Do infectious agents drive lymphoma initiation?
Find out next week during the 3rd webinar of the Pathogens and Lymphoma Series with Catherine Thieblemont, Ayako Arai, Amira Marouf, Florence Broussais-Guillaumot and Sonali Smith
Register ➡️ us06web.zoom.us/webinar/regi...

2 1

Erica Wood @ericawood.bsky.social · Jul 11

Please join us for this Maddie Riewoldt's Vision online event on Wed 23 July to hear how patients and families can participate in the Aplastic Anaemia & Other Bone Marrow Failure Syndromes Registry and the Australian Marrow Failure Biobank

Register at www.mrv.org.au/research/scientific-events

2